AVE 50.0% 0.3¢ avecho biotechnology limited

bby coverage - price target 17c, page-8

  1. 5,322 Posts.
    Hi PoS- some great posts there and thankyou for the welcome back. Im pleased to habve 2009 behind me.

    The BBY report is a an interesting read although I think they compiled it after reading Hot Copper and ralised they were falling behind on their analysis- so a good report but 17cts target price??

    Strange that the last BBY Report had if I recall correctly a Target price of 16 cents without the Oxy deal factored in. So an Oxycodone TPM Patch commercialised is worth ONE CENT to POHs valuation....give us a break BBY.

    I haver posted endlessly about the value of an Oxy deal for POH. Apart from sending the sp short term through the stratosphere- it will validate POHs science and trigger a rerating of the rest of POHs drug pipeline.

    Meanwhile POH needs a new house broker and fast.. BBY- its time to GO

    KC
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(50.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.2¢ 0.3¢ 0.2¢ $52 21.66K

Buyers (Bids)

No. Vol. Price($)
11 6846739 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 41919123 29
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.